Business and science: Quantum computing aroun...

GLP-1 weight-loss drugs such as Ozempic, Wegovy, Mounjaro and Zepbound are reshaping the treatment of obesity around the world. But even when these medicines are judged “cost-effective”, access often depends on who can afford to pay. In the second episode of our Business Daily se ...  Show more

GLP-1 weight-loss drugs such as Ozempic, Wegovy, Zepbound and Mounjaro are reshaping the treatment of obesity — and transforming the global pharmaceutical market.Originally developed to treat type-2 diabetes, these injectable medicines — including semaglutide and tirzepatide — ar ...  Show more

Tech companies and labs around the world are building a revolutionary new computer. Quantum computers harness the mysteries of quantum physics to perform calculations that seem impossible. The people building them say they’re going to change the world.

In a new seaso ...

Tech companies including Google, Microsoft and IBM are all working on plans for a commercially viable quantum computer. They say that these machines will be able to solve climate change, help develop new pharmaceutical drugs and transform our economy. But harnessing quantum ph ...

A bonus episode to go with our Quantum Revolution season. The FT’s John Thornhill and Madhumita Murgia host a panel of experts at the Founders Forum conference, discussing the promise of quantum computing and the state of the quantum industry today. Featuring Steve Brierley, f ...

In the latest episode of the What the FinTech? podcast, we’re joined by Dr Philip Intallura, Head of Quantum Technologies at HSBC, to learn more about quantum computing and the impact the growth and maturation of the technology could have on financial services. Phil and FinTech F ...  Show more